Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Payables: 2015-2025

Historic Payables for HUTCHMED (China) (HCM) over the last 3 years, with Jun 2025 value amounting to $67.8 million.

  • HUTCHMED (China)'s Payables rose 1718.34% to $67.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $197.0 million, marking a year-over-year increase of 33.46%. This contributed to the annual value of $65.9 million for FY2024, which is 2.35% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Payables stood at $67.8 million, which was up 2.96% from $65.9 million recorded in Q4 2024.
  • HUTCHMED (China)'s Payables' 5-year high stood at $68.1 million during Q4 2021, with a 5-year trough of -$26.9 million in Q2 2022.
  • Moreover, its 3-year median value for Payables was $65.9 million (2024), whereas its average is $47.4 million.
  • Per our database at Business Quant, HUTCHMED (China)'s Payables plummeted by 200.15% in 2022 and then skyrocketed by 1,718.34% in 2025.
  • HUTCHMED (China)'s Payables (Quarterly) stood at $68.1 million in 2021, then plummeted by 35.09% to $44.2 million in 2022, then surged by 52.70% to $67.5 million in 2023, then fell by 2.35% to $65.9 million in 2024, then spiked by 1,718.34% to $67.8 million in 2025.
  • Its Payables stands at $67.8 million for Q2 2025, versus $65.9 million for Q4 2024 and -$4.2 million for Q2 2024.